Kyle Machynia
Physician Assistant • Reno, NV
500 Damonte Ranch Pkwy Ste 1056
Reno, NV 895215901
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on September 6, 2016; this date does not establish years in practice.
-
Published CMS data list 5,934 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 17003 — Destruction of precancer skin growth, 2-14 growths: 2,977 service units.
- 99213 — Established patient outpatient office visit: 873 service units.
- 17000 — Destruction of precancer skin growth, 1 growth: 638 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 22 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,016 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Triamcinolone Acetonide — 197 prescription fills, including refills.
- Ketoconazole — 186 prescription fills, including refills.
- Doxycycline Hyclate — 127 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 20 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Physician Assistant in Reno, NV (2024, 132 clinicians with data). Median for this group: 381. Middle half: 160 to 873.
More Medicare Part B services than 95% of clinicians listed under Physician Assistant in Nevada (2024, 551 clinicians with data). Median for this group: 239. Middle half: 99 to 900.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 3,858 in 2020 to 5,934 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
500 Damonte Ranch Pkwy Ste 1056
Reno, NV 895215901
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Integrated Dermatology Of Reno-Mortensen Pllc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
2016
What Public CMS Data Show
Physician Assistant: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
750 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $240,933 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $166,131 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
1,148 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$451,969 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $61,223.52 across 297 records.
By nature of payment (3 largest of 5)
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $41,668.00 across 27 records.
- Travel and Lodging: $7,230.87 across 17 records.
- Food and Beverage: $7,063.90 across 244 records.
Reporting-company totals (3 largest of 19)
- Janssen Pharmaceuticals, Inc: $33,270.90 across 62 records.
- Galderma Laboratories, L.P.: $9,051.84 across 24 records.
- ABBVIE INC.: $7,882.35 across 47 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
10 years (graduated 2016)
CMS Doctors and Clinicians data list 2016 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2016
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Kyle Machynia has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Kyle Machynia as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Reno and Nevada
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Physician Assistant in Reno, NV (2024, 132 clinicians with data). Median for this group: 381. Middle half: 160 to 873.
More Medicare Part B services than 95% of clinicians listed under Physician Assistant in Nevada (2024, 551 clinicians with data). Median for this group: 239. Middle half: 99 to 900.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Physician Assistant in Reno, NV (2024, 132 clinicians with data). Median for this group: $29,997. Middle half: $14,291 to $62,844.
A higher Medicare-allowed amount than 95% of clinicians listed under Physician Assistant in Nevada (2024, 551 clinicians with data). Median for this group: $19,039. Middle half: $8,218 to $51,606.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Physician Assistant in Reno, NV (2024, 132 clinicians with data). Median for this group: $20,311. Middle half: $10,562 to $46,188.
A higher Medicare payment amount than 95% of clinicians listed under Physician Assistant in Nevada (2024, 551 clinicians with data). Median for this group: $14,357. Middle half: $5,921 to $37,821.
Medicare Part D prescriptions
More Part D prescriptions than 70% of clinicians listed under Physician Assistant in Reno, NV (2024, 148 clinicians with data). Median for this group: 254. Middle half: 118 to 1,203.
More Part D prescriptions than 70% of clinicians listed under Physician Assistant in Nevada (2024, 617 clinicians with data). Median for this group: 324. Middle half: 94 to 1,300.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Physician Assistant in Reno, NV (2024, 148 clinicians with data). Median for this group: $3,407. Middle half: $1,084 to $73,027.
A higher Part D drug cost than 90% of clinicians listed under Physician Assistant in Nevada (2024, 617 clinicians with data). Median for this group: $7,774. Middle half: $876 to $106,842.
234 active clinicians are listed under Physician Assistant with a practice address in Reno, NV (1,084 in Nevada).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Reno
12.8% of these 234 clinicians have the CMS telehealth indicator.
70.5% of these 234 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 54% from 3,858 in 2020 to 5,934 in 2024.
- 2020: 3,858
- 2021: 5,592
- 2022: 5,728
- 2023: 5,519
- 2024: 5,934
-
Medicare-allowed amount
Medicare-allowed amount increased 44% from $167,412 in 2020 to $240,933 in 2024.
- 2020: $167,412
- 2021: $249,577
- 2022: $258,179
- 2023: $230,721
- 2024: $240,933
-
Paid by Medicare
Paid by Medicare increased 28% from $130,279 in 2020 to $166,131 in 2024.
- 2020: $130,279
- 2021: $189,285
- 2022: $187,767
- 2023: $160,232
- 2024: $166,131
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 36% from 748 in 2020 to 1,016 in 2024.
- 2020: 748
- 2021: 801
- 2022: 1,003
- 2023: 864
- 2024: 1,016
-
30-day fills
30-day fills increased 45% from 794 in 2020 to 1,148 in 2024.
- 2020: 794
- 2021: 881
- 2022: 1,100
- 2023: 1,006
- 2024: 1,148
-
Part D drug cost
Part D drug cost increased 175% from $164,262 in 2020 to $451,969 in 2024.
- 2020: $164,262
- 2021: $300,502
- 2022: $285,124
- 2023: $215,301
- 2024: $451,969
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 2578% from $2,286.08 in 2021 to $61,223.52 in 2025.
- 2021: $2,286.08
- 2022: $4,323.93
- 2023: $8,794.92
- 2024: $42,391.47
- 2025: $61,223.52
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 297 records totaling $61,223.52.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Janssen Pharmaceuticals, Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
TREMFYA | General | $3,150.00 |
| Janssen Pharmaceuticals, Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
TREMFYA | General | $3,150.00 |
| Janssen Pharmaceuticals, Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
TREMFYA | General | $3,150.00 |
| Janssen Pharmaceuticals, Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
TREMFYA | General | $3,150.00 |
| Janssen Pharmaceuticals, Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
TREMFYA | General | $3,150.00 |
| Janssen Pharmaceuticals, Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
TREMFYA | General | $2,800.00 |
| Galderma Laboratories, L.P. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
— | General | $2,700.00 |
| Janssen Pharmaceuticals, Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
TREMFYA | General | $2,025.00 |
| Galderma Laboratories, L.P. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
NEMLUVIO | General | $1,800.00 |
| Eli Lilly and Company |
Consulting Fee
Cash or cash equivalent
|
EBGLYSS | General | $1,800.00 |
| Galderma Laboratories, L.P. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
NEMLUVIO | General | $1,800.00 |
| Janssen Pharmaceuticals, Inc |
Travel and Lodging
In-kind items and services
|
TREMFYA | General | $1,636.28 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
RINVOQ | General | $1,500.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
RINVOQ | General | $1,500.00 |
| Sanofi and Genzyme US Companies |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $1,380.00 |
| Janssen Pharmaceuticals, Inc |
Travel and Lodging
In-kind items and services
|
TREMFYA | General | $1,301.62 |
| Janssen Pharmaceuticals, Inc |
Travel and Lodging
In-kind items and services
|
TREMFYA | General | $1,253.30 |
| Janssen Pharmaceuticals, Inc |
Travel and Lodging
In-kind items and services
|
TREMFYA | General | $1,253.30 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
SKYRIZI | General | $1,250.00 |
| Galderma Laboratories, L.P. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
NEMLUVIO | General | $1,125.00 |
| Eli Lilly and Company |
Consulting Fee
Cash or cash equivalent
|
EBGLYSS | General | $1,050.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
SKYRIZI | General | $900.00 |
| Janssen Pharmaceuticals, Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
TREMFYA | General | $900.00 |
| Janssen Pharmaceuticals, Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
TREMFYA | General | $900.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
RINVOQ | General | $900.00 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
17003
Destruction of precancer skin growth, 2-14 growths
|
2,977 | 414 | $9.83 | $5.47 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
873 | 570 | $133.46 | $74.79 |
|
17000
Destruction of precancer skin growth, 1 growth
|
638 | 492 | $99.87 | $40.46 |
|
17110
Destruction of skin growth, 1-14 growths
|
411 | 326 | $168.10 | $88.07 |
|
17004
Destruction of precancer skin growth, 15 or more growths
|
185 | 124 | $246.75 | $136.25 |
|
J3301
Injection, triamcinolone acetonide, not otherwise specified, 10 mg
|
157 | 39 | $1.42 | $0.97 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
122 | 122 | $163.43 | $92.21 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
82 | 61 | $188.73 | $101.11 |
|
11301
Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm
|
80 | 68 | $178.63 | $84.56 |
|
11311
Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm
|
54 | 46 | $200.95 | $102.50 |
|
96372
Injection of drug or substance under skin or into muscle
|
46 | 37 | $21.04 | $11.71 |
|
11602
Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm
|
40 | 36 | $361.15 | $99.79 |
|
11310
Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less
|
39 | 34 | $168.65 | $80.64 |
|
11306
Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm
|
37 | 35 | $180.52 | $93.60 |
|
13121
Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm
|
36 | 33 | $625.52 | $339.77 |
|
11300
Shaving of skin growth of body, arms, or legs, 0.5 cm or less
|
31 | 28 | $147.80 | $60.10 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
29 | 29 | $83.13 | $47.01 |
|
11102
Biopsy of related skin growth, first growth
|
26 | 26 | $147.80 | $62.75 |
|
13101
Complicated repair of wound of trunk, 2.6-7.5 cm
|
22 | 21 | $583.02 | $315.76 |
|
17262
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
|
19 | 16 | $262.95 | $121.48 |
|
11302
Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm
|
18 | 18 | $201.51 | $104.49 |
|
11305
Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less
|
12 | 12 | $154.66 | $65.38 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Triamcinolone Acetonide | Triamcinolone Acetonide | 197 | 6,541 | $2,893.13 | 142 |
| Ketoconazole | Ketoconazole | 186 | 5,858 | $3,305.92 | 102 |
| Doxycycline Hyclate | Doxycycline Hyclate | 127 | 3,940 | $2,021.97 | 45 |
| Cephalexin | Cephalexin | 67 | 789 | $433.51 | 50 |
| Dupixent Pen | Dupilumab | 60 | 1,666 | $230,102.18 | — |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 46 | 1,298 | $851.08 | 21 |
| Mometasone Furoate | Mometasone Furoate | 45 | 1,300 | $782.34 | 20 |
| Mupirocin | Mupirocin | 33 | 837 | $204.74 | 26 |
| Valacyclovir | Valacyclovir Hcl | 33 | 436 | $764.19 | 22 |
| Ciclopirox | Ciclopirox | 27 | 840 | $720.94 | 20 |
| Fluorouracil | Fluorouracil | 26 | 695 | $1,700.50 | 26 |
| Terbinafine Hcl | Terbinafine Hcl | 25 | 1,776 | $198.36 | 19 |
| Tacrolimus | Tacrolimus | 25 | 642 | $1,398.98 | 24 |
| Taltz Autoinjector | Ixekizumab | 25 | 700 | $204,595.92 | — |
| Finasteride | Finasteride | 20 | 1,314 | $140.11 | — |
| Econazole Nitrate | Econazole Nitrate | 19 | 503 | $446.98 | 13 |
| Clindamycin Phosphate | Clindamycin Phosphate | 17 | 510 | $459.25 | 13 |
| Clobetasol Propionate | Clobetasol Propionate | 16 | 531 | $830.40 | — |
| Fluconazole | Fluconazole | 11 | 273 | $70.98 | — |
| Acyclovir | Acyclovir | 11 | 110 | $47.77 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2026-08-04NUCC Taxonomy Code: 363A00000X
A physician assistant is a person who has successfully completed an accredited education program for physician assistant, is licensed by the state and is practicing within the scope of that license. Physician assistants are formally trained to perform many of the routine, time-consuming tasks a physician can do. In some states, they may prescribe medications. They take medical histories, perform physical exams, order lab tests and x-rays, and give inoculations. Most states require that they work under the supervision of a physician.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - PHYSICIAN ASSISTANT
I20161013001834
NV
3678861226
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Integrated Dermatology Of Reno-Mortensen Pllc
500 Damonte Ranch Pkwy, Reno, NV 895215901
Phone: 7758291212
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Dermatology
Doctor of Medicine (M.D.)
Dermatology
Physician Assistant (Certified)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 500 DAMONTE RANCH PKWY STE 1056, RENO, NV 895215901 (Tel: 7755885000)
Registered at 4700 EXCHANGE CT STE 110, BOCA RATON, FL 334314450 (Tel: 5619480291)
Physician Assistant (license number reported to NPPES: NV PA1762)
NPI status registered as active in NPPES database
Registered at 276 KINGSBURY GRADE, SUITE 101, STATELINE, NV 894499804 (Tel: 7755885000)
Registered at PO BOX 5910, STATELINE, NV 894495910 (Tel: 7755885000)
Recorded as KYLE MACHYNIA
Physician Assistant (license number reported to NPPES: NV PA1762)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Physician Assistants in Reno
- Cheyanne Annis, PA-S
- Theresa Ineck, PA-C
- Shanae Vizza, PA-C
- Amy Schoening, PA-C
- Adam Casey, PA
- Kala Scoggin, PA
Mailing Address
4700 Exchange Ct Ste 110
Boca Raton, FL 334314450
Phone: 5619480291